Skip to main navigation Skip to search Skip to main content

Ibrutinib Treatment in Waldenström's Macroglobulinemia: Follow-up Efficacy and Safety from the iNNOVATETM Study

  • Christian Buske
  • , Alessandra Tedeschi
  • , Judith Trotman
  • , Ramon García-Sanz
  • , David MacDonald
  • , Véronique Leblond
  • , Beatrice Mahe
  • , Charles Herbaux
  • , Constantine S. Tam
  • , M. Lia Palomba
  • , Jeffrey V Matous
  • , Chaim Shustik
  • , Eftathios Kastritis
  • , Steven P Treon
  • , Chih-Jian Lih
  • , Jianling Li
  • , Zeena Salman
  • , Thorsten Graef
  • , Meletios A Dimopoulos
  • University of Ulm
  • ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • University of Sydney
  • Hospital Universitario de Salamanca, Salamanca, Spain
  • University of Ottawa
  • University of Paris
  • Centre Hospitalier Universitaire de Nantes, Nantes, France.
  • Centre Hospitalier Régional Universitaire de Lille, Institute of Hematolog-Tranfusion, Lille, France
  • Peter MacCallum Cancer Centre
  • Memorial Sloan-Kettering Cancer Center
  • Colorado Blood Cancer Institute, Denver, CO
  • McGill University Health Centre
  • National and Kapodistrian University of Athens
  • Harvard University
  • Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA.

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalBlood
Volume132
DOIs
StatePublished - Nov 21 2018
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Family Medicine

Cite this